Sequenom (SQNM +12.2%) shares surge today after the American College of Obstetricians and...
Sequenom (SQNM +12.2%) shares surge today after the American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee issue a joint opinion recommending that cell-free fetal DNA testing be offered to patients at increased risk of aneuploidy, and also as a follow-up test for women with a positive first-trimester or second-trimester screening test result.
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs